Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Note 16 - Income Taxes (Tables)

v3.8.0.1
Note 16 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Statement Line Items [Line Items]  
Schedule of deferred tax assets [text block]
    December 31,
2017
    December 31,
2016
    December 31,
2015
 
          As recast
(note 3(b))
    As recast
(note 3(b))
 
                   
Net operating losses carried forward   $
15,645
    $
11,743
    $
8,099
 
Research and development expenditures    
5,450
     
5,098
     
4,946
 
Equipment book over tax depreciation    
410
     
368
     
354
 
Intangible asset    
2,464
     
2,307
     
2,238
 
Undeducted financing costs    
273
     
270
     
281
 
Ontario Research and Development Tax Credit    
427
     
398
     
388
 
Cumulative eligible capital    
284
     
267
     
288
 
Unrecognized deferred tax asset   $
24,953
    $
20,451
    $
16,594
 
Schedule of unusued tax losses [text block]
       
2026   $
6
 
2027    
3,460
 
2028    
2,978
 
2029    
522
 
2030    
2,313
 
2031    
2,053
 
2032    
2,767
 
2033    
5,977
 
2034    
4,558
 
2035    
8,988
 
2036    
13,520
 
2037    
11,859
 
    $
59,001
 
Schedule of effective income tax rate reconciliation [text block]
    Year ended
December 31,
2017
    Year ended
December 31,
2016
    Year ended
December 31,
2015
 
          As recast
(note 3(b))
    As recast
(note 3(b))
 
                   
Loss before income taxes   $
(11,661
)   $
(14,240
)   $
(11,711
)
Statutory Canadian corporate tax rate    
26.5
%    
26.5
%    
26.5
%
                         
Anticipated tax recovery   $
(3,090
)   $
(3,773
)   $
(3,103
)
Non-deductible permanent differences    
220
     
412
     
604
 
Change in deferred tax benefits deemed not probable to be recovered    
4,502
     
3,434
     
2,606
 
Change in substantively enacted rates    
51
     
 
     
 
 
Foreign exchange differences    
(1,391
)    
 
     
 
 
Other    
(292
)    
(73
)    
(107
)
    $ -     $ -     $ -